A new study suggests the connection between Attention-Deficit/Hyperactivity Disorder (ADHD) and the body’s primary stress ...
Attention deficit hyperactivity disorder (ADHD) is the most common disability diagnosis in children globally. It's estimated ...
Groundbreaking research has uncovered a set of just three gene variants that can increase the likelihood of attention-deficit ...
Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded ...
Powerful psychotropic drugs are often the next step, even though their combined effects in young children haven’t been ...
Pfizer and Tris Pharma have agreed to pay $41.5m to settle allegations by the Texas Attorney General Ken Paxton ...
Attention-deficit/hyperactivity disorder (ADHD) symptoms are influenced by socioeconomic factors in regions affected by ...
Co-occurring ADHD and substance use create unique challenges. The latest research shows what effective treatment really ...
Clear structure, calm communication, and simple, predictable habits can make daily life far smoother for families, helping ...
Pfizer Inc. and Tris Pharma Inc. will pay the state of Texas $41.5 million to settle claims that it allegedly provided ...
Taking acetaminophen during pregnancy is not clearly linked to autism or attention-deficit/hyperactivity disorder (ADHD) in ...
In two newly published studies, researchers at the Department of Ethology, Eötvös Loránd University (Hungary) investigated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results